Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Capnocytophaga spp. DF-1 pneumonia in an immune-competent 56-year old man post-CABG

B Wilde1, S F Angel, J M Blondeau

  • 1Department of Clinical Microbiology, Royal University Hospital and Saskatoon Health Region, University of Saskatchewan, Canada.

Journal of Chemotherapy (Florence, Italy)
|March 18, 2008
PubMed

Insights

This study details a rare case of Capnocytophaga pneumonia in a post-surgery patient. It highlights the importance of recognizing Capnocytophaga species (DF-1) in hospital-acquired infections.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Background:

  • Nosocomial pneumonia poses a significant threat to immunocompromised patients.
  • Capnocytophaga species are emerging pathogens, particularly in vulnerable populations.
  • Coronary artery bypass grafting (CABG) patients are at increased risk for nosocomial infections.

Observation:

  • A 56-year-old male developed pneumonia after CABG surgery.
  • The patient was intubated and mechanically ventilated.
  • Capnocytophaga spp. DF-1 was identified as the causative agent.

Findings:

  • This case represents a rare instance of Capnocytophaga spp. DF-1-induced pneumonia in a post-CABG patient.
  • A review of Capnocytophaga species infections and their antibiotic susceptibilities is provided.
  • Understanding the spectrum of Capnocytophaga infections is crucial for effective management.

Implications:

  • Early recognition and appropriate antibiotic therapy are vital for improving outcomes in Capnocytophaga infections.
  • This case underscores the need for vigilance regarding unusual pathogens in intensive care settings.
  • Further research into Capnocytophaga spp. DF-1 pathogenesis and treatment is warranted.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.